Johanna Walther

Delivery Aspects of CRISPR/Cas for in Vivo Genome Editing

Danny Wilbie, Johanna Walther, Enrico Mastrobattista · Accounts of Chemical Research · 2019 · 290 citations · Full text

Life Sciences, Genetics, Molecular Biology +17

A novel orally available small molecule that inhibits hepatitis B virus expression

H. Mueller, Steffen Wildum, Souphalone Luangsay et al. · Journal of Hepatology · 2017 · 141 citations · Full text

Pharmacy, Infectious Diseases, Medicinal Chemistry +17

Metabolic Profiling of Human Long-Term Liver Models and Hepatic Clearance Predictions from In Vitro Data Using Nonlinear Mixed-Effects Modeling

Nicole A. Kratochwil, Christophe Meille, Stephen Fowler et al. · The AAPS Journal · 2017 · 109 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +17

Liver-Targeted Anti-HBV Single-Stranded Oligonucleotides with Locked Nucleic Acid Potently Reduce HBV Gene Expression In Vivo

Hassan Javanbakht, H. Mueller, Johanna Walther et al. · Molecular Therapy — Nucleic Acids · 2018 · 71 citations · Full text

Life Sciences, Biotechnology, Molecular Biology +16

Comparative analysis of lipid Nanoparticle-Mediated delivery of CRISPR-Cas9 RNP versus mRNA/sgRNA for gene editing in vitro and in vivo

Johanna Walther, Deja Porenta, Danny Wilbie et al. · European Journal of Pharmaceutics and Biopharmaceutics · 2024 · 63 citations · Full text

Life Sciences, Biotechnology, Molecular Biology +17